KODIAK SCIENCES INC.: diluted weighted-average shares
Diluted weighted-average shares for KODIAK SCIENCES INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All KODIAK SCIENCES INC. financial histories
What this measure means
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
Exact concept: us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2020-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.
Reading these values
This selected numerical history matches Basic weighted-average shares for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.
Context from the filing
For 2023–2025, Kodiak uses net loss attributable to common stockholders as its EPS numerator and excludes potential common shares as antidilutive in the loss periods. The 2023 comprehensive-loss figure is a separate measure and does not replace net loss for EPS. Shares and per-share amounts are exempt from the thousands heading and use scale-zero tags. Excluded common-share equivalents are not added to the weighted-average denominator. Read the source filing.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 53,208,311 | shares | 2026-03-31 | 10-K · 0001193125-26-134887 |
| 2024-01-01 | 2024-12-31 | 52,583,148 | shares | 2026-03-31 | 10-K · 0001193125-26-134887 |
| 2023-01-01 | 2023-12-31 | 52,414,256 | shares | 2026-03-31 | 10-K · 0001193125-26-134887 |
| 2022-01-01 | 2022-12-31 | 52,249,620 | shares | 2025-03-27 | 10-K · 0000950170-25-046098 |
| 2021-01-01 | 2021-12-31 | 51,788,918 | shares | 2024-03-28 | 10-K · 0000950170-24-038025 |
| 2020-01-01 | 2020-12-31 | 45,741,845 | shares | 2023-03-28 | 10-K · 0000950170-23-010314 |
Related financial histories
- KODIAK SCIENCES INC.: total assets
- KODIAK SCIENCES INC.: total liabilities
- KODIAK SCIENCES INC.: stockholders equity
- KODIAK SCIENCES INC.: cash and cash equivalents
- KODIAK SCIENCES INC.: net income or loss
- KODIAK SCIENCES INC.: operating cash flow
- KODIAK SCIENCES INC.: capital expenditure payments
- KODIAK SCIENCES INC.: financing cash flow
- KODIAK SCIENCES INC.: investing cash flow
- KODIAK SCIENCES INC.: retained earnings or deficit
- KODIAK SCIENCES INC.: basic weighted-average shares
- KODIAK SCIENCES INC.: basic earnings per share
- KODIAK SCIENCES INC.: diluted earnings per share
- KODIAK SCIENCES INC.: income tax expense or benefit
- KODIAK SCIENCES INC.: net property, plant and equipment
- KODIAK SCIENCES INC.: share-based compensation expense
- KODIAK SCIENCES INC.: operating income or loss
- KODIAK SCIENCES INC.: current assets
- KODIAK SCIENCES INC.: interest expense
- KODIAK SCIENCES INC.: current liabilities
- KODIAK SCIENCES INC.: current accounts payable
- KODIAK SCIENCES INC.: common-stock repurchase payments
- KODIAK SCIENCES INC.: operating expenses
- KODIAK SCIENCES INC.: research and development expense
Inspect the source
- Entity
- KODIAK SCIENCES INC. / CIK 0001468748
- Captured
- 2026-09-20T09:07:12.598Z
- SEC response SHA-256
fa937f3241c45706b9bd1bff3d57d7c6bde0b88302772aa7c62bc4ffe51766d7
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001468748.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))